Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award President and CEO acquired 8,334 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 8,334 shares (grant or award)
  4. 4 Grant or award Chief Research Officer acquired 833 shares (grant or award)
  5. 4 Grant or award General Counsel and Secretary acquired 833 shares (grant or award)
  6. 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
  12. 4 Grant or award Chief Financial Officer acquired 506 shares (grant or award)
  13. 4 Planned sale General Counsel and Secretary sold 272 shares at $10.32 ($2,807)
  14. 4 Open-market sale Chief Research Officer sold 154 shares at $10.32 ($1,589)
  15. 4 Open-market sale Chief Medical Officer sold 290 shares at $10.32 ($2,993)
  16. 4 Open-market sale President and CEO sold 1,526 shares at $10.32 ($15,748)
  17. 4 Open-market sale Chief Medical Officer sold 238 shares at $10.03 ($2,386)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 14 · 269 filings